Oxford Finance
Oxford Finance is a specialty finance firm with a long-established enterprise-lending franchise serving life sciences, healthcare, SaaS, fintech, and other growth companies.
- Venture debt and growth-credit investment firm
- Venture Debt & Growth Credit
- Tier II
Overview
Oxford Finance is a specialty finance firm with a long-established enterprise-lending franchise serving life sciences, healthcare, SaaS, fintech, and other growth companies. Its facilities can finance clinical and commercial milestones, acquisitions, working capital, and expansion.
The firm remained highly active in 2026, completing large growth financings for technology and payments businesses while also expanding leveraged lending and asset-based capabilities. Its dedicated sector teams allow the platform to distinguish development-stage life sciences risk from revenue-backed growth credit. Within The Economy Wiki, the institution is connected to the Venture Debt & Growth Credit market category.
Firm facts
| Institution | Oxford Finance |
| Type | Venture debt and growth-credit investment firm |
| Headquarters | Alexandria, United States |
| Founded | 2002 |
| Primary ranking focus | Venture Debt & Growth Credit |
| Highest 2026 tier | Tier II |
Activities and credit capabilities
Oxford Finance operates within non-dilutive growth finance for venture-backed and scaling companies. Its activities are assessed through the category-specific capabilities summarized below.
Venture debt
Loans designed for venture-backed companies between equity-financing rounds.
Growth credit
Flexible debt for commercially established businesses funding expansion.
Founder financing
Capital structured to extend runway while limiting immediate equity dilution.
Strategy and transaction coverage
Strategy and asset coverage
Technology; software; life sciences; fintech; climate; consumer and other growth sectors
Financing and transaction contexts
Term loans; revolving facilities; recurring-revenue loans; equipment finance; acquisition and runway capital
Market position
Oxford fits Tier II because it combines specialist healthcare and innovation expertise with substantial hold capacity and broader specialty-finance infrastructure.
Oxford Finance is assessed within the Venture Debt & Growth Credit framework. For wider market context, see Growth Equity vs Venture Capital and Buyouts: Key Differences.
Competitive context
Oxford Finance is recognized Tier II in Top 30 Venture Debt & Growth Credit 2026. The rankings compare institutions by market relevance, origination or operating capability, underwriting or platform depth, institutional credibility and current activity. Comparable links support navigation and do not imply that every institution competes for every financing or mandate.
Leadership and governance
Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through Oxford Finance’s official website.
| Leadership area | Current source |
|---|---|
| Investment and operating leadership | Current team and governance information |
Corporate and public information
This profile refers to Oxford Finance as the public-facing organization. Individual funds, management companies, advisers, lending entities and regulated affiliates may use separate legal names across jurisdictions.
Corporate and disclosure information
| Organization | Oxford Finance |
| Headquarters | Alexandria, United States |
| Public website | oxfordfinance.com |
| Profile basis | Public institutional information and Capital Ranking editorial research |
Ranking recognition
Related Economy analysis
Selected Economy Markets articles provide context for the lending, financing, diligence and private-market themes relevant to this institution:
- Growth Equity vs Venture Capital and Buyouts: Key Differences
- Private Credit’s Trillion-Dollar Growth Meets Its AI Debt Test
- Technology Private Equity: Scale, Due Diligence and the Small-Cap Advantage
